收费全文 | 1793篇 |
免费 | 109篇 |
国内免费 | 12篇 |
耳鼻咽喉 | 11篇 |
儿科学 | 55篇 |
妇产科学 | 49篇 |
基础医学 | 239篇 |
口腔科学 | 29篇 |
临床医学 | 216篇 |
内科学 | 469篇 |
皮肤病学 | 28篇 |
神经病学 | 187篇 |
特种医学 | 58篇 |
外科学 | 145篇 |
综合类 | 7篇 |
预防医学 | 134篇 |
眼科学 | 36篇 |
药学 | 124篇 |
肿瘤学 | 127篇 |
2023年 | 22篇 |
2022年 | 9篇 |
2021年 | 57篇 |
2020年 | 55篇 |
2019年 | 63篇 |
2018年 | 61篇 |
2017年 | 51篇 |
2016年 | 50篇 |
2015年 | 67篇 |
2014年 | 90篇 |
2013年 | 107篇 |
2012年 | 160篇 |
2011年 | 138篇 |
2010年 | 96篇 |
2009年 | 90篇 |
2008年 | 135篇 |
2007年 | 127篇 |
2006年 | 120篇 |
2005年 | 100篇 |
2004年 | 103篇 |
2003年 | 76篇 |
2002年 | 67篇 |
2001年 | 10篇 |
2000年 | 6篇 |
1999年 | 7篇 |
1998年 | 13篇 |
1997年 | 5篇 |
1996年 | 5篇 |
1995年 | 8篇 |
1994年 | 4篇 |
1993年 | 1篇 |
1992年 | 5篇 |
1987年 | 1篇 |
1984年 | 1篇 |
1983年 | 1篇 |
1978年 | 1篇 |
1975年 | 1篇 |
1973年 | 1篇 |
Methods: A total of 1684 SLE patients from the BLISS-52 (n = 865) and BLISS-76 (n = 819) trials were surveyed. Physician’s Global Assessment (PGA) scores <0.5 (3-point scale) were used for comparisons. We used the chi-square test for comparisons and the phi coefficient for correlations.
Results: At week 52, LLDAS was achieved by 8.6% of patients, cSLEDAI-2K = 0 by 34.5% and SRI-4 by 45.1%. cSLEDAI-2K = 0 showed the strongest correlation with PGA <0.5 (rφ = 0.36, P < 0.001). cSLEDAI-2K = 0 unveiled the superiority of belimumab 10 mg/kg over placebo (P = 0.003) with a magnitude which was comparable to that of SRI-4 (P < 0.001). LLDAS displayed a more moderate separation (P = 0.033).
Conclusions: LLDAS was a stringent measure. cSLEDAI-2K = 0 showed the strongest correlation with the clinician-based evaluation. Being based on the SLEDAI-2K only, cSLEDAI-2K = 0 may be considered a more pragmatic outcome measure in SLE studies compared with composite tools. 相似文献
Methods: The study included 314 subjects (42 bipolar-BD patients; 21 manics and 21 depressives, 68 unipolar-UD, and 204 normal controls-NC). Analysis of Covariance (ANCOVA) and the calculation of the Relative Risk (RR) and the Odds Ratio (OR) were used for the analysis.
Results: Paternal age differed between NC and UD patients (29.42?±?6.07 vs. 32.12?±?5.54; p?=?.01) and manics (29.42?±?6.07 vs. 35.00?±?5.75; p?=?.001) and maternal age between NC and manics (25.46?±?4.52 vs. 31.43?±?4.75; p?<?.001) and manic and UD (31.43?±?4.75 vs. 26.75?±?6.03; p?=?.002). The RR and OR values suggested that advanced parental age constitutes a risk factor for the development of mood disorders.
Conclusions: In a non-dose dependent and gender-independent, advanced parental age constitutes a risk factor for the development of BD with index episode of mania (probably manic predominant polarity); only advanced paternal age constitutes a risk factor for the development of UD and BD with index episode of depression (probably depressive predominant polarity). This is the first study suggesting differential effect of advanced parental age depending on predominant polarity of BD. 相似文献